Advanced MRI measures to stage and monitor multiple sclerosis

Reporting Quantitative Microstructural MRI Metrics to Stage and Monitor Multiple Sclerosis

NIH-funded research Microstructure Imaging, INC. · NIH-11189717

This project uses advanced diffusion MRI measurements to better track disease stage and progression in people with multiple sclerosis.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionMicrostructure Imaging, INC. NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11189717 on NIH RePORTER

What this research studies

You would get MRI scans that use diffusion techniques to measure tiny tissue features in your brain, not just overall volume or lesions. The team will build a reference database of these microstructural metrics matched by age and sex and compare individual scans to that norm. They plan to apply a standard white-matter model that separates intra-axonal, extra-axonal, and free-water signals to help tell inflammation from degeneration. The work also aims to make these measurements reliable across different MRI scanners so changes can be detected sooner than with conventional volumetrics.

Who could benefit from this research

Good fit: Adults with a diagnosis of multiple sclerosis who can undergo brain MRI and share clinical or imaging data would be the best candidates.

Not a fit: People who cannot have MRI (for example due to implanted metal devices or severe claustrophobia) or those without MS are unlikely to benefit from this work.

Why it matters

Potential benefit: If successful, this could detect neurodegeneration and treatment effects earlier and more precisely than current MRI measures, helping guide care decisions.

How similar studies have performed: Research using diffusion MRI and compartmental white-matter models has shown promise and often outperforms simple volume measures, but widespread clinical adoption is still limited.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.